Ashwagandha for PCOS: The Real Evidence and the Real Risks

Does Ashwagandha Treat PCOS, or Just Lower Cortisol in People Who Don’t Have It?

Zero published human trials have measured ashwagandha’s effect on menstrual cycles, ovulation, androgen levels, or insulin resistance in women actually diagnosed with PCOS. Nearly every ashwagandha-for-PCOS article online cites the same handful of cortisol and anxiety trials — and those trials were run in stressed adults with no PCOS diagnosis at all. The logic being borrowed goes: PCOS involves a dysregulated stress axis, ashwagandha lowers cortisol, therefore it should help PCOS. That is a mechanism theory, not a measured outcome, and this page keeps those two things separate rather than blurring them the way most sources do.

The one exception sits in rats, not people. A 2016 study induced PCOS-like changes in 24 female rats with 21 days of letrozole, then treated them for 28 days with a combination of Withania somnifera (ashwagandha) and Tribulus terrestris extract. The combination normalized the disrupted estrus cycle and reversed the letrozole-driven rises in luteinizing hormone, estradiol, and testosterone, alongside a drop in total cholesterol. That is the only PCOS-model evidence ashwagandha has — it is a rat study, it tested a two-herb combination rather than ashwagandha alone, and 28 days in a rat estrus cycle does not translate to a dosing timeline in a human menstrual cycle. Citing it as if it were human PCOS evidence would be the same extrapolation this page is trying not to make.

What Do the Human Ashwagandha Trials Actually Measure?

Every human RCT behind the “ashwagandha for stress” claim enrolled generally stressed adults, not women with PCOS, and ran for 8 to 12 weeks at doses far lower than what most retail bottles market as a “PCOS dose.”

In the largest pooled analysis, 23 trials in 1,706 adults found ashwagandha significantly reduced cortisol and increased serotonin — a real, replicated stress-axis effect. Chandrasekhar’s 60-day trial found a similarly significant cortisol drop (P = 0.0006) alongside reduced stress-scale scores. Neither trial measured a single PCOS-relevant outcome — no cycle length, no ovulation, no androgen panel, no HOMA-IR. The cortisol effect is real; the PCOS benefit is inferred, not measured.

Does Ashwagandha Raise Testosterone? The Split That Actually Matters Here

Ashwagandha raised testosterone by a pooled mean of 57.43 ng/dL in men across the 23-trial meta-analysis, but showed no significant change in women (mean difference 5.09 ng/dL) — a statistically significant difference by sex. That split is the single most PCOS-relevant fact in the entire evidence base, because a supplement that raised androgens would be actively harmful for a hyperandrogenic phenotype, and most ashwagandha-for-PCOS content never mentions it either way.

In the Lopresti trial that measured this directly, testosterone increased in men (P = 0.038) but not in women (P = 0.989) over the 60-day period, though the male-female difference did not reach significance against placebo (P = 0.158) in that smaller sample. Taken together with the larger meta-analysis, the honest reading is reassuring but incomplete: the trials that exist did not find ashwagandha raising testosterone in women — but none of those women had PCOS, and none had baseline androgen levels anywhere near what a hyperandrogenic phenotype presents with. “Doesn’t raise testosterone in androgen-normal, non-PCOS women” is not the same finding as “doesn’t raise testosterone in women who already have excess androgen,” and no trial has tested the second question.

Is Ashwagandha Safe If You’re Trying to Conceive or Pregnant?

No ashwagandha trial has enrolled a pregnant or breastfeeding participant, which means there is no human dosing safety data for this population at all — a gap that matters enormously on a site where a large share of readers are actively trying to conceive. Ashwagandha has a long history of traditional use in Ayurvedic medicine as an abortifacient and emmenagogue, a use documented in the World Health Organization’s 2009 monograph on the plant. A 2026 systematic and ethnobotanical review pushed back on how solid that historical claim actually is, arguing that citation distortion across secondary sources has overstated the human evidence, while animal reproductive-toxicity studies at doses relevant to human use found no significant fetal or maternal harm — this finding is worth naming honestly rather than dropping, because it complicates the simple “proven abortifacient” framing many sites use. But that dispute does not change the practical bottom line: whichever mechanism claim turns out to be right, zero human pregnancy safety data exists either way, and two of the liver-injury case reports below describe patients who started ashwagandha specifically while trying to conceive.

Does Ashwagandha Affect Your Thyroid If You Have Hashimoto’s or Take Levothyroxine?

Ashwagandha raised T3 and T4 and improved TSH in a randomized trial of 50 people with subclinical hypothyroidism, and a much larger pooled analysis found the same direction of effect in a broader population. An 8-week trial of 600 mg daily significantly improved TSH (P < 0.001), T3 (P = 0.0031), and T4 (P = 0.0096) compared with placebo in people who started with elevated TSH. The 23-trial meta-analysis found no pooled effect on TSH or T3, but a modest, statistically significant T4 increase (mean difference 0.61 µg/dL, P = 0.02) across a broader, not-specifically-hypothyroid population. Read together, the two data points agree on direction even where they disagree on magnitude: ashwagandha pushes thyroid hormone output up, and it pushes it up more in someone whose thyroid was already under-functioning.

This is not a footnote for PCOS readers specifically, because Hashimoto’s thyroiditis is roughly 2.7 times more common in women with PCOS than in controls (odds ratio 2.69, 95% CI 1.63–4.42), pooled across 22 studies. Stacking a compound that raises T4 on top of a levothyroxine dose that is already calibrated to a specific TSH target is a real interaction, not a theoretical one — and it can show up as symptoms rather than just a lab number. Watch for heart palpitations, tremor, heat intolerance, unintended weight loss, or new anxiety that feels different from your baseline; those are the recognizable signs of thyroid hormone running higher than your body is used to, developing over days to a few weeks rather than appearing instantly. The full PCOS-thyroid overlap and what testing actually looks like covers the broader comorbidity in more depth.

Can Ashwagandha Cause Liver Damage? What the Case Reports Actually Show

Ashwagandha has a dedicated entry in the NIH’s LiverTox database, which states plainly that it “has not been implicated in causing serum enzyme elevations during therapy but recently has been implicated in cases of clinically apparent liver injury” — a shift from years of apparent safety to a now-documented, if uncommon, risk. The pattern across published case series is consistent enough to describe: jaundice and dark urine appearing 2 weeks to several months after starting or increasing the dose, often with itching and fatigue, in a liver-enzyme pattern that is mixed or cholestatic rather than the pattern typical of a classic hepatocellular drug injury.

The Iceland/US series found five cases of liver injury in adults ages 21 to 62, presenting with symptoms and jaundice 2 to 12 weeks after starting the supplement, with every case resolving within 1 to 5 months and no fatalities. The India case series is the harder read: of 8 cases, 5 had pre-existing chronic liver disease, and 3 of those progressed to acute-on-chronic liver failure and died, while the cases without underlying liver disease resolved — pre-existing liver disease is the variable that separates a self-limited injury from a fatal one, not the ashwagandha dose alone. Two individual case reports describe patients taking ashwagandha specifically for fertility support: a 36-year-old man on 450 mg three times daily for six months, and a 30-year-old woman on 450 mg once daily for six weeks, both developing jaundice that resolved within two months of stopping — a direct, documented instance of this exact reader situation.

Recognize the pattern early rather than waiting for it to worsen: yellowing of the skin or the whites of the eyes, urine that looks like dark tea or cola, stools that turn pale or clay-colored, persistent itching without a rash, and fatigue or right-upper-abdominal discomfort that doesn’t match anything else going on. These typically build over one to several weeks, not hours.

Is Ashwagandha Safe With Autoimmune Disease or Immunosuppressants?

Ashwagandha’s traditional pharmacology profile includes documented immune-modulating activity — it is described in the foundational review of the plant’s evidence base as having, among other properties, immunomodulatory and hemopoietic effects alongside its anti-stress and antioxidant activity. A compound that modulates immune activity is a plausible reason for caution in autoimmune disease, where the concern is a supplement nudging an already-overactive immune response, and alongside an immunosuppressant, where the concern runs the opposite direction — an added immune-modulating compound complicating a drug regimen calibrated to suppress that same system. Neither direction has a dedicated PCOS-population safety trial, which is consistent with the pattern across this entire page: the mechanism is documented, the population-specific trial is not. If you have an autoimmune condition — including Hashimoto’s, which co-occurs with PCOS far more often than in the general population — or take an immunosuppressant for any reason, that is a conversation for your prescriber before adding this supplement, not a decision to make from a label alone.

Who This Won’t Help, and Who Should Skip It Entirely

Ashwagandha will not help you if you are looking for a tested effect on your menstrual cycle, ovulation, or androgen levels — no trial has measured any of those outcomes in PCOS, so there is no evidence base to draw a timeline or an expected effect size from. It is not a fit if you are pregnant, breastfeeding, or trying to conceive, given the complete absence of human pregnancy safety data regardless of how the abortifacient debate resolves. Skip it, or use it only under supervision, if you have any liver disease, take levothyroxine or have Hashimoto’s without a plan to recheck labs, have an autoimmune condition, or take an immunosuppressant. And if your main goal is androgen reduction or insulin improvement specifically, the trials reviewed here simply never tested for that in a PCOS population — the honest answer is that this remains unmeasured, not that it has been measured and found ineffective.

You may see PCOS written as polyendocrine metabolic ovarian syndrome (PMOS), after a 2026 global consensus of more than 50 organisations renamed it. Nothing about the evidence gap described above changed with the name — this article uses PCOS because that is still what most readers search.

Your Next Step

If cortisol and stress are what actually brought you here, the cortisol and stress mechanism in PCOS covers that connection directly rather than through a supplement. If you are weighing ashwagandha against something else you are already taking, the supplement interaction checker is the faster way to spot a conflict than reading every label by hand. For the wider evidence picture across every compound this site has reviewed, the full supplements evidence guide covers what else has trial data behind it in PCOS specifically — and the supplements section has the complete list. Comparing this against another adaptogen or a different hormone-support herb? Ashwagandha vs holy basil and ashwagandha vs maca each weigh this evidence and risk profile against a specific alternative.